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We  developed  an assay  to  quantify  respiratory  chain  deﬁciencies  in single  neurons.
Quadruple-label  immunoﬂuorescence  was  combined  with  quantitative  image  analysis.
The  single-cell  assay  was  applied  to tyrosine  hydroxylase-positive  midbrain  neurons.
The  expression  of  complexes  I  and  IV  was  determined  relative  to  mitochondrial  mass.
The  assay  proved  speciﬁc  in  patients  with  known  respiratory  chain  deﬁciencies.
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Background:  Respiratory  chain  (RC)  deﬁciencies  are  found  in primary  mtDNA  diseases.  Focal  RC defects
are  also  associated  with ageing  and neurodegenerative  disorders,  e.g. in substantia  nigra  (SN)  neurons
from  Parkinson’s  disease  patients.  In mitochondrial  disease  and  ageing,  mtDNA  mutational  loads  vary
considerably  between  neurons  necessitating  single  cell-based  assessment  of  RC  deﬁciencies.  Evaluating
the full  extent  of  RC  deﬁciency  within  SN neurons  is challenging  because  their size precludes  investiga-
tions  in  serial  sections.  We  developed  an  assay  to measure  RC  abnormalities  in  individual  SN neurons
using  quadruple  immunoﬂuorescence.
New  method:  Using  antibodies  against  subunits  of complex  I (CI)  and  IV,  porin  and  tyrosine  hydroxylase
together  with  IgG subtype-speciﬁc  ﬂuorescent  labelled  secondary  antibodies,  we  quantiﬁed  the expres-
sion of CI  and CIV  compared  to  mitochondrial  mass  in dopaminergic  neurons.  CI:porin  and  CIV:porin
ratios  were  determined  relative  to a standard  control.
Results:  Quantiﬁcation  of expression  of  complex  subunits  in midbrain  sections  from  patients  with  mtDNA
disease  and  known  RC deﬁciencies  consistently  showed  reduced  CI:porin  and/or  CIV:porin  ratios.
Comparison  with  existing  method(s):  The  standard  histochemical  method  to investigate  mitochondrial
dysfunction,  the  cytochrome  c oxidase/succinate  dehydrogenase  assay,  measures  CIV  and  CII  activities.
To  also  study  CI  in  a patient,  immunohistology  in additional  sections,  i.e. in  different  neurons,  is required.
Our method  allows  correlation  of  the expression  of  CI, CIV  and  mitochondrial  mass  at  a single  cell  level.
Conclusion:  Quantitative  quadruple-label  immunoﬂuorescence  is a reliable  tool  to measure  RC  deﬁcien-
cies  in individual  neurons  that  will  enable  new  insights  in  the molecular  mechanisms  underlying  inherited
and  acquired  mitochondrial  dysfunction.
© 2014  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
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. Introduction
The oxidative phosphorylation (OXPHOS) system comprises
pproximately 85 polypeptides. These polypeptides assemble (i)
our respiratory chain (RC) complexes, complex I (CI) to complex
V (CIV), (ii) one complex facilitating adenosine triphosphate (ATP)
eneration, complex V (CV), and (iii) two mobile electron carriers,
oenzyme Q (CoQ) and cytochrome c (Mitchell, 1961). The OXPHOS
ystem is situated in the lipid bilayer of the inner mitochondrial
embrane (Hateﬁ, 1985; Saraste, 1999). The passage of electrons
rom CI or CII via CIII and CIV catalyzes the transfer of protons from
he mitochondrial matrix across the inner mitochondrial mem-
rane to the inter-membrane space building an electrochemical
radient. This gradient is the driving force for CV, ATP synthase,
o generate ATP from ADP and inorganic phosphate (Hateﬁ, 1985;
araste, 1999).
RC enzyme deﬁciency, in particular involving CI and CIV
Greaves et al., 2010; Reeve et al., 2008; Swalwell et al., 2011), is
resent in patients with primary mitochondrial diseases (DiMauro
nd Schon, 2003). In addition, there is increasing evidence for a
ole of RC enzyme deﬁciency in ageing and neurodegenerative dis-
ases such as Parkinson’s disease (PD) (Bender et al., 2006; Langston
t al., 1983; Schapira et al., 1989). In primary mitochondrial DNA
mtDNA) diseases, dysfunction of RC enzyme complexes is due to
nherited mutations in the mitochondrial genome with the level of
eteroplasmy (mutational burden) varying considerably between
ells (Taylor and Turnbull, 2005). In PD, and normal human age-
ng, an accelerated accumulation of somatic mtDNA deletions in
ubstantia nigra neurons has been reported (Bender et al., 2006;
raytsberg et al., 2004). As a consequence of varying mutational
oads, cells differ in the degree of OXPHOS deﬁciency which neces-
itates analysis on a single cell level to determine the nature of
he biochemical defect. In many tissues (e.g. skeletal muscle, large
ntestine), information concerning RC activities and expression lev-
ls can be obtained from sequential sections (Campbell et al., 2013;
reaves et al., 2010; Rowan et al., 2012). In the CNS, however, inves-
igations concerning RC enzyme function and abundance have so
ar been performed in populations rather than single cells, since the
ize of most neuron types, including the dopaminergic neurons of
he substantia nigra, precludes serial studies.
To enable us to simultaneously explore the degree of deﬁciency
f CI and CIV (both of which have mtDNA-encoded subunits) in
ingle dopaminergic neurons from postmortem midbrain tissue,
e have established a quantitative immunoﬂuorescent protocol for
uadruple labelling.
. Materials and methods
.1. Human tissue
Skeletal muscle tissue was obtained from an elderly control, fol-
owing informed consent, with age-related RC deﬁciencies (age: 78,
ex: female) and snap frozen in isopentane at −160 ◦C. Muscle was
yrosectioned (10 m)  and sections allowed to air dry for 60 min  at
oom temperature (RT) before immunohistology or histochemistry
as performed.
Brain tissue was provided by the Newcastle Brain Tissue
esource (NBTR) with ethical approval. To optimize the quadruple
abelling immunoﬂuorecence protocol, post-mortem brain sam-
les were obtained from two patients with mitochondrial disease
xhibiting CI and CIV deﬁciencies, one idiopathic Parkinson disease
atient (age: 77, sex: female) and one control with no neurolog-
cal phenotype (age: 55, sex: male). The mitochondrial disease
atients included one individual with MERRF due to the m.8344A>G
utation (age: 58, sex: male) and one patient with Kearns Sayrence Methods 232 (2014) 143–149
syndrome (KSS) due to a single, large-scale mtDNA deletion (age:
40, sex: female) (Reeve et al., 2013). Sections of formalin-ﬁxed
parafﬁn-embedded midbrain blocks were cut at 5 m using a
microtome (Microm International) and mounted on to Super-
FrostTM slides (Thermo Fisher Scientiﬁc).
2.2. Immunoﬂuoresence labelling and histochemistry with
muscle sections
For immunoﬂuorescent staining, snap frozen muscle sections
were dried, ﬁxed in 4% (w/v) paraformaldehyde (PFA) for 10 min
and then washed three times for 2 min  in Tris-buffered saline con-
taining 1% Tween-20 (TBST). Sections were then blocked in TBST
and 1% (v/v) normal goat serum (NGS) for 1 h at RT. Monoclonal
mouse antibodies against complex I-20 (NDUFB8, IgG subtype
1, Abcam, ab110242), and CIV-1 (COX1, IgG subtype 2a, Abcam,
ab14705) were diluted 1:100 in 1% NGS and incubated over night at
4 ◦C. To remove unbound primary antibodies, sections were washed
three times in TBST for 5 min. Then IgG subtype-speciﬁc secondary
anti-mouse antibodies conjugated to Alexa ﬂuor 488 and 546 (both
Life Technologies, A21131 and A21143, respectively) were applied
(1:100 in 1% NGS TBST) for 60 min  at RT. Again, sections were
washed three times for 5 min  in TBST. To quench autoﬂuorescence,
Sudan black (0.3% w/v in 70% v/v ethanol) solution was applied for
10 min  followed by three short washes in TBST. Finally, sections
were mounted in Prolong Gold Antifade Reagent (Life Technolo-
gies).
For immunohistology with chromogens, air-dried muscle sec-
tions were ﬁxed in 4% PFA for 10 min, followed by rinsing in TBST
for 10 min. The sections were permeabilized in a graded (70%, 95%,
100%, 100%, 95%, 70% v/v, 10 min  each) methanol series. Endoge-
nous peroxidase activity was quenched by addition of hydrogen
peroxide 0.3% (v/v) to 95% (v/v) methanol. Sections were rinsed
in TBST and blocked in 5% (w/v) BSA TBST for 30 min at RT. Next,
sections were incubated overnight with anti-CI-20 and CIV-1 anti-
bodies (1:100 in 5% (w/v) BSA TBST) at 4 ◦C. Following three washes
in TBST, sections were treated with the MenaPath kit accord-
ing to manufacturer’s protocol (Menarini Diagnostics). After ﬁve
washes in TBST for 5 min, peroxidase activity was detected by
incubation in 3,3′-diaminobenzadine tetrahydrochloride solution
(SigmaFast DAB tablets dissolved in distilled water) for 5 min at
RT.
CIV (COX) histochemical activity in muscle was  detected using
a published technique (Johnson et al., 1988).
2.3. Immunoﬂuorescence with midbrain sections
To deparafﬁnize and rehydrate, parafﬁn-ﬁxed midbrain sections
were incubated at 60 ◦C for 30 min. This was followed by sequential
washing steps in Histoclear (2 times for 5 min) (National Diag-
nostics), and a graded ethanol series (100%, 100%, 95%, 70% v/v,
5 min  each). Next, sections were washed in distilled water. Anti-
gen retrieval was  performed in 1 mM EDTA, pH 8, in a pressure
cooker for 40 min  followed by another wash in distilled water
and a short wash in TBST. Sections were blocked in TBST and
1% (v/v) NGS for 1 h at RT. Monoclonal mouse antibodies against
CI-20, CIV-1, the mitochondrial mass marker porin (IgG subtype
2b, Abcam, ab14734) and a rabbit polyclonal antibody directed
against the dopaminergic marker tyrosine hydroxylase (TH, Sigma,
T8700) were used at a concentration of 1:100. Midbrain sections
were incubated in the primary antibody dilution overnight at 4 ◦C.
This was  followed by three wash steps for 5 min  in TBST. For
quadruple immunoﬂuorescent labelling, midbrain sections were
incubated with IgG subtype-speciﬁc secondary anti-mouse anti-
bodies conjugated with Alexa Fluor 488, 546 or 647 (A21240) and
a secondary anti-rabbit Alexa Fluor 405 (A31556) antibody (all Life
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Fig. 1. Correlation of respiratory chain complex expression and enzyme activity in serial skeletal muscle sections from a control with age-related RC deﬁciencies. (a and b)
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tmmunohistological detection of CI-20 and CIV-1 with chromogens or ﬂuorescence
uscle  ﬁbres of the mitochondrial disease patient is detectable in sequential se
istochemistry. COX activity corresponds to CIV-1 expression in individual muscle
echniques.
echnologies, 1:100) for 1 h at RT. Next, sections were washed 3
imes for 5 min  in TBST and then incubated in Sudan black solu-
ion for 10 min. This was followed by three washes in TBST and
ounting in Prolong Gold (Life Technologies).
.4. Fluorescence microscopy imaging and densitometric analysis
Imaging of midbrain sections was performed using the epi-
uorescence Axio Imager M1  (Zeiss) microscope. Fluorophores of
econdary antibodies were chosen so that cross-talk, i.e. overlap
etween their absorption and emission spectra, was  minimized.
ingle-label controls were used to determine the remaining frac-
ion of “bleed-through” between different ﬁlters and the lower
ignal threshold was adjusted accordingly during imaging. To fur-
her avoid cross-talk, the ﬂuorophore with longest peak emission
avelength was imaged ﬁrst. Dopaminergic neurons were identi-
ed by their neuromelanin deposits and TH-positive staining. In
cquired images, all detectable dopaminergic neurons were ana-
yzed independent of cellular morphology or protein abundance of
I-20, CIV-1 or porin up to a total cell number of 100. For densit-
metric analysis of the target proteins, Image J Software (version
.46r) was used. Images from the four channels were imported as
n image sequence. The background signal for all antibodies was
etermined in a non-stained area. In each channel, the threshold
as adjusted according to the background signal and kept constant
etween different sections for each individual. Cells were outlined
anually according to their TH signal. Within these deﬁned areas,
ean signal intensities of all channels were determined simulta-
eously using the “analyze stack” function in Image J.
Images of sequential muscle sections were also acquired using
he Axio Imager M1  (Zeiss)..5. Statistical analysis
Prism version 4.01 and the non-parametric Mann–Whitney
est were used to compare intensities between individuals as theing. Increased (#) or decreased (*) immunoreactivity of CI-20 or CIV-1 in individual
 independent of the visualization method used. (c) Cytochrome c oxidase (COX)
 of the control individual, conﬁrming good correlation between the two different
obtained densitometric data from cellular analysis were not nor-
mally distributed.
3. Results
3.1. Detection of RC enzyme activities and protein levels in serial
muscle sections from a mitochondrial disease case
Serial sections of skeletal muscle from an elderly control sub-
ject with age-related RC deﬁciencies were employed to test the
compatibility of two  immunohistology approaches – use of (i) chro-
mogens or (ii) ﬂuorescence labelling for visualization of target
proteins. Both assays were applied to sequential muscle sections
to investigate the expression of CI and CIV. We chose to exam-
ine subunit 1 of CIV, as expression levels had been reported to
correlate with activity in this complex (Mahad et al., 2009). Fur-
thermore, an antibody against subunit 20 of CI was employed
which had previously been shown to reliably detect deﬁciencies
of RC CI in tissue from mtDNA disease patients (Reeve et al., 2013).
Both immunohistology approaches identiﬁed identical ﬁbres as CI
and/or CIV-deﬁcient independent of the immunohistology method
used. A small number of ﬁbres also showed increased levels of CI
and/or CIV expression (Fig. 1a and b).
For CIV, a histochemical technique allows measurement of
cytochrome c oxidase (COX) activity in tissue samples. The method
uses 3,3′-diaminobenzidine (DAB) which is oxidized by functional
CIV, forming a brown pigment. Consequently, cells with dys-
functional CIV will remain free of the DAB oxidation product. In
concordance with previous studies (Mahad et al., 2009; Tanji and
Bonilla, 2008), COX activity corresponded well with CIV-1 expres-
sion (Fig. 1c), indicating loss of activity as a result of loss of the
catalytic subunit of CIV in some of the muscle ﬁbres. In the case of
CI, a direct correlation of protein expression and activity on single
cell level is not possible as there is currently no available protocol to
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uantify NADH:ubiquinone oxidoreductase histochemical activity
eliably.
.2. Quadruple immunoﬂuorescence and expression analysis of
itochondrial proteins at a single neuron level in midbrain
ections
In contrast to muscle ﬁbres, midbrain neurons commonly do
ot reach beyond the section thickness of 5 m.  Information on
he expression of multiple RC enzyme complexes in an individual
euron can, therefore, not be obtained from the analysis of sequen-
ial sections. Due to this limitation and following the observation
f a link between CIV activity and expression, we established an
mmunohistology protocol which allows simultaneous detection of
I-20 and CIV-1 normalized to mitochondrial mass in dopaminergic
eurons. As a mitochondrial marker, the highly abundant ion chan-
el forming protein porin (which spans the outer mitochondrial
embrane) was used (Colombini, 1980). Porin is a nuclear-encoded
itochondrial protein which is preserved in the presence of mtDNA
isease (Blachly-Dyson et al., 1994). An antibody directed against
yrosine hydroxylase which catalyzes the rate limiting step in
opamine synthesis (Flatmark and Stevens, 1999) was  used to iden-
ify dopaminergic neurons.
The main hurdle with the investigation of proteins in brain sec-
ions by means of ﬂuorescent immunohistology is the interference
f autoﬂuorescence with the target signal. This autoﬂuorescence
s, on the one hand, caused by lipofuscin pigment which is present
t high concentrations in postmitotic cells such as neurons. On
he other hand, autoﬂuorescence can be ﬁxative-induced since
ldehydes react with proteins generating ﬂuorescent products
Billinton and Knight, 2001). To counteract autoﬂuorescence, we
ncubated the midbrain sections in Sudan black as a ﬁnal step before
mage analysis (Romijn et al., 1999).
To test the speciﬁcity of our protocol, we used midbrain sec-
ions from a patient with a single large-scale mtDNA deletion, a
atient with the m.8344A>G mutation causing MERRF, a PD patient
nd an elderly neurologically normal control individual. CI-20 and
IV-1 expression had previously been studied in populations of
opaminergic neurons in the substantia nigra of both mitochon-
rial disease patients (cases “MERRF2” and “Single deletion 1” in
eeve et al. (2013)). This analysis revealed 44% of completely CI-
0-deﬁcient and only 1% of completely CIV-1-deﬁcient cells in the
ingle mtDNA deletion case. In the m.8344A>G MERRF patient,
2% of dopaminergic midbrain neurons were completely deﬁ-
ient of CI-20 and 23% were completely deﬁcient of CIV-1 (Reeve
t al., 2013). The quadruple-label immunoﬂuoresence images also
howed isolated CI-20 deﬁciency for the single large-scale mtDNA
eletion patient and combined CI-20 and CIV-1 deﬁciency for the
.8344A>G patient (Fig. 2). In comparison, microscopy images of
idbrain sections of the PD patient indicated a joint loss of CI-
0 and CIV-1 with a slight trend towards CI deﬁciency (Fig. 2,
ight panel). In addition, respiratory chain enzyme deﬁciencies
oincided with elevated porin levels in MERRF disease patient
eurons consistent with evidence of increased mitochondrial
iogenesis.
To quantify the expression of CI-20, CIV-1 and porin, we  estab-
ished an image analysis protocol in Image J. After background
orrection, pixel intensities within areas of interest (deﬁned by
he outlines of TH-positive neurons) were determined. The CI-
0:porin, CIV-1:porin and CI-20:CIV-1 ratios were calculated for
pproximately 100 neurons in the substantia nigra of a control
rain section. Median ratios for the control neurons were deter-
ined and set to 100%. The expression ratios of all individual
ells (from patients and the control) were expressed relative to
he control median. This approach was repeated three times using
ifferent midbrain sections from the same individuals. In eachnce Methods 232 (2014) 143–149
experiment, CI expression in the single, large-scale mtDNA dele-
tion patient (who was found to be more severely affected than the
m.8344A>G MERRF patient according to Reeve et al. (2013)) was
indeed lower than in the m.8344A>G MERRF patient (Fig. 3a, left
panel). The total median ratios derived from the combined data
of all experimental runs supported this observation (CI-20:porin:
control, 100%; single large-scale mtDNA deletion, 19%, p < 0.001;
m.8344A>G MERRF, 33%, p < 0.001; PD, 32%, p < 0.001) (Fig. 3a, right
panel). The CIV-1:porin ratios also showed deﬁciency but the ﬁnd-
ings in the different patients varied from the CI deﬁciency. Taking
all runs together, we determined a median CIV-1:porin ratio of 60%
(p < 0.001) for the single large-scale mtDNA deletion patient, of 32%
(p < 0.001) for the m.8344A>G MERRF patient and 42% (p < 0.001) for
the PD patient (Fig. 3b). For the mitochondrial disease patients, this
ﬁnding was  again consistent with previous data from cell popula-
tion analyses (Reeve et al., 2013). When the CI-20:CIV-1 ratios were
plotted, a marked shift towards CI deﬁciency was observed for the
single mtDNA deletion patient with 67% (p < 0.001) less CI-20 than
CIV-1. In case of the PD patient, this ratio indicated 23% (p < 0.001)
less CI-20 than CIV-1. By contrast, the m.8344A>G MERRF patient
showed a CI-20:CIV-1 similar to the control (Fig. 3c). These quan-
titative ﬁndings reﬂected the impressions obtained from visual
inspection of the immunolabeled midbrain sections (Figs. 2 and 3).
4. Discussion
In primary mtDNA disease, different mtDNA mutations and
mutation heteroplasmy levels cause great variability in the degree
of mitochondrial dysfunction in different cell populations. Under
these circumstances functional analyses in single cells are pre-
ferred over investigations in tissue homogenates. The standard
approach to investigate mitochondrial function on single cell
level is the COX/SDH assay (Old and Johnson, 1989). This his-
tochemical method gives information about the activity of RC
complexes IV and II with CII activity serving as a marker of
mitochondrial mass. In contrast, there is currently no histochem-
ical protocol available which allows accurate determination of
CI (rotenone sensitive NADH:ubiquinone oxidoreductase) activ-
ity in individual cells in tissue sections. However, like CIV, CI
deﬁciency has been reported in PD (Schapira et al., 1989). To
study CI expression in tissue, immunohistology with chromogens
is commonly used. This method is limited to the application
of one antibody at the time. Consequently, the expression of
RC complex subunits cannot be normalized for mitochondrial
abundance and correlations between different proteins on sin-
gle cell level are precluded. Therefore, to determine the degree
of deﬁciency of CI and to investigate the relationship between
CI and CIV in single neurons, immunoﬂuorescence labelling is
required.
When comparing CIV histochemistry and immunohistology
readouts from consecutive muscle sections, we found, in con-
cordance with earlier studies, that CIV activity and expression
correlated in the majority of ﬁbres (Koob et al., 2012; Siskova et al.,
2010). Since there is no histochemical assay to reliably detect CI
activity in addition to CIV activity, we established a protocol that
allows simultaneous detection and expression quantiﬁcation of
four target proteins in individual neurons from postmortem mid-
brain tissue. We  quantiﬁed the protein levels of CI-20, CIV-1 and
mitochondrial porin in neurons that expressed tyrosine hydrox-
ylase as a marker of dopaminergic signalling. To verify the assay,
midbrain sections from mitochondrial disease patients with known
CI and/or CIV deﬁciencies were subjected to the protocol. We  con-
sistently identiﬁed the single large-scale mtDNA deletion patient
as the mitochondrial disease case with most severe CI deﬁciency
and the m.8334A>G MERRF patient as the case with most severe
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Fig. 2. Fluorescence labelling immunohistology of complex I-20, complex IV-1, porin and tyrosine hydroxylase (TH) in dopaminergic midbrain neurons of an age-matched
control, patients with mitochondrial disease and PD. Epiﬂuorescence microscopy images of the employed four ﬂuorescence channels (emission wavelengths: 405 nm,  488 nm,
546  nm and 647 nm)  were taken with exposure times that were kept constant across the different investigated midbrain sections. Images indicate differences in protein
expression of respiratory chain enzyme subunits and mitochondrial mass between patients and control. Taking porin levels into account, the single large-scale mtDNA
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Peletion patient showed isolated CI deﬁciency, whereas the m.8344A>G MERRF and
euromelanin deposits (dark areas in brightﬁeld channel) point towards the dopa
hown in all channels. MERRF – myoclonic epilepsy and ragged-red ﬁbre disease, P
IV deﬁciency. These results are in line with previous ﬁndings
sing chromogens (Reeve et al., 2013). The observed variation
n level of deﬁciency is likely due to the use of different mid-
rain sections from the same individual in different experimental
uns. Interestingly, respiratory chain enzyme deﬁciencies were
ccompanied by an increase in mitochondrial mass in mtDNA dis-
ase patient neurons resulting in very low Cx:porin ratios. We
ypothesize that additional mitochondria are generated through
iogenesis to compensate for the reduced OXPHOS capacity in
hese cells. However, these new mitochondria also lack functional
espiratory chain complexes as indicated by low CI:porin (and
IV:porin) ratios. By contrast, in the PD patient SN neurons only slight increase in mitochondrial mass was detected. In cellu-
ar models of PD, impaired mitochondrial maintenance has been
dentiﬁed as the underlying pathological mechanism (de Vries and
rzedborski, 2013). The observed changes in CI, CIV and porinD patients showed combined loss of CI and CIV expression. Positive TH staining and
gic character of the investigated neurons. The outlines of TH-positive neurons are
rkinson disease, Sng del – single large-scale mtDNA deletion.
levels may  therefore be a result of reduced mitochondrial turnover
by autophagy.
In summary, we established quadruple immunoﬂuorescence
together with densitometric imaging analysis as tools to quan-
tify protein levels of subunits of multiple RC enzyme complexes
in single neurons. Applying our method, the relationship between
RC complexes can be studied in discrete cell types in the brain
with availability of cell type-speciﬁc antibodies being the only
limitation. This proves particularly useful when investigating the
molecular causes of mitochondrial diseases or neurodegenera-
tive disorders which can both affect various brain regions. Using
quadruple immunoﬂuorescence in combination with LCM and DNA
analysis, (i) RC enzyme deﬁciencies may  further be ascribed to a
speciﬁc genetic defect in the mtDNA and (ii) the heteroplasmy
threshold for developing a RC defect can be determined within a
single cell.
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Fig. 3. Densitometry analysis of complex I-20 and complex IV-1 expression in dopaminergic midbrain neurons from one control individual, and patients with mitochondrial
disease  or PD. Data from consecutive experiments is shown in the left panel and the combined results per person are given in the right panel. (a and b) The protein levels
of  CI-20 and CIV-1 of individual neurons were expressed relative to the mitochondrial mass marker porin. This analysis consistently showed lower CI-20 than CIV-1 levels
in  single large-scale mtDNA deletion patient neurons when compared to control neurons. By contrast, a patient with m.8344A>G MERRF presented with a combined loss
of  CI and CIV expression in all analyzed midbrain sections. Similarly, in a PD patient, reduced CI-20 and CIV-1 levels were detected in all individual runs. (c) Calculation of
the  CI-20 to CIV-1 ratio showed a clear shift towards CI deﬁciency only in the neurons of the single large-scale mtDNA deletion patient. Protein levels were determined in
50–100  neurons per section and four sections per individual from four independent experimental runs were analyzed. Tyrosine hydroxylase (TH) staining was used to identify
d ernal 
m rkins
F
t
mopaminergic neurons. The control ratio was set to 100% in each run serving as int
arked as a line. MERRF – myoclonic epilepsy and ragged-red ﬁbre disease, PD – Pa
inancial disclosuresThe funders had no role in study design, data collec-
ion and analysis, decision to publish, or preparation of the
anuscript.standard. Dots indicate ratios per individual cell and the median of each dataset is
on disease, Sng del – single large-scale mtDNA deletion. *p < 0.05; ***p < 0.001.
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